ATHENA develops surrogate organ program for toxicity testing Creating surrogate human being organs.

ATHENA develops surrogate organ program for toxicity testing Creating surrogate human being organs, coupled with insights from highly sensitive mass spectrometry technologies, a fresh project is on the brink of revolutionizing the way we screen new drugs and toxic agents. ATHENA, the Advanced Tissue-engineered Human being Ectypal Network Analyzer task team, is definitely developing four human organ constructs – liver, center, lung and kidney – that are based on a miniaturized platform significantly. Each organ component will be about how big is a smartphone screen, and the whole ATHENA ‘body’ of interconnected organs would fit neatly on a table caverta 100 .

Klein stated that knowledge of the presence of the ATM gene could lead to better screening for pancreatic tumor, the fourth most common reason behind cancer-related death. However, there are no recommended screening tests currently. Many doctors make use of endoscopy as a screening tool for pancreatic cancer, but researchers are evaluating this system in clinical trials still.. ATM gene mutations may enhance hereditary risk for pancreatic cancer Mutations in the ATM gene might raise the hereditary risk for pancreatic cancer tumor, according to data published in Cancers Discovery, the newest journal of the American Association for Cancer Research. Pancreatic cancer is among the most morbid cancers, with significantly less than 5 % of those diagnosed with the condition surviving to five years.